ArticleJournal of oncology practice2015

Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor.

Terhi T O Hermanson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.